Increased integration and synergy in EEG- and fNIRS-based data in migraine patients after a three-month treatment with galcanezumab: relations with long-term clinical outcome.

Figure 6 displays the individual trajectories for EEG and fNIRS global efficiency across the different time points, highlighting inter-individual variability while showing an overall trend toward normalization to normal values after three months of treatment.

also in 4,871 other papers